besity is recognized as an important risk factor for the development of all features of metabolic syndrome and atherosclerotic cardiovascular disease. [1] [2] [3] [4] [5] [6] [7] [8] [9] An estimation of visceral adipose tissue is important, and several methods are applied as a surrogate for the assessment of body composition and visceral adipose tissue.
Epicardial adipose tissue is true visceral fat deposited around the heart, particularly around subepicardial coronary vessels. While little is known about the pathophysiologic and metabolic roles of epicardial fat, it has been implicated in the development of coronary atherosclerosis. 10 Recent reports have shown that epicardial adipose tissue expresses numerous genes for cytokines and proteins associated with atherosclerosis. [11] [12] [13] The association between epicardial fat and coronary artery disease has not been studied in clinical settings. Transthoracic echocardiography provides a reliable measurement of epicardial fat thickness. 14 Thus, the present study was designed to assess the association between epicardial fat thickness, measured using transthoracic echocardiography, and the severity of coronary artery stenosis.
Methods

Study Population
Two hundred and three consecutive patients, who underwent coronary angiography, were studied. The patients' clinical diagnoses on admission were acute myocardial infarction in 74 patients (36.5%), unstable angina in 106 patients (51.1%) and stable angina in 23 patients (11.3%). We excluded patients who had severe degree of valvular heart disease (3 patients), cardiomyopathy (1 patient) and pericardial effusion (1 patient). Moreover, we excluded those whose transthoracic echocardiographic imaging was inadequate for the measurement of epicardial fat thickness (14 patients).
On admission, blood sampling was performed to measure total cholesterol, triglyceride, high-density lipoproteincholesterol, low-density lipoprotein-cholesterol, lipoprotein (a), fibrinogen and high-sensitivity C-reactive protein in overnight fasting state. Height (m) and body weight (kg) were used to calculate body mass index.
Coronary Angiography
In a fasting state, coronary angiography was performed using the Judkins' method, following the puncture of the femoral artery or via a radial artery approach. The severity of coronary atherosclerotic lesions was evaluated from at 
O
least 3 projections in all the patients. Significant stenosis was defined as a diameter stenosis of 50% or greater. The angiographic characteristics of the coronary atherosclerotic lesion were defined using Gensini's score. 15 In this scoring system, a greater reduction of the luminal diameter is assigned a high score and a proximal lesion in the left anterior descending or the left circumflex artery is assigned a higher score than a distal lesion.
Echocardiographic Measurement
Each patient underwent transthoracic echocardiography the next day after coronary angiography. Echocardiograms were performed with a VIVID 7 (GE, USA) instrument according to standard techniques, with subjects in the left lateral decubitus position. Echocardiographic images were recorded onto a computerized database and videotape. The offline measurement of epicardial fat thickness was performed by 2 cardiologists who were unaware of the clinical and angiographic data.
We measured epicardial fat thickness on the free wall of right ventricle from the parasternal long-axis views. Epicardial fat was identified as an echo-free space in the pericardial layers on the 2-dimensional echocardiography, and its thickness was measured perpendicularly on the free wall of the right ventricle at end-diastole for 3 cardiac cycles. 14, 16 In order to standardize the measuring point between different observers, we used the aortic annulus as anatomical reference. The measurement was performed at a point on the free wall of the right ventricle along the midline of the ultrasound beam, perpendicular to the aortic annulus (Fig 1) . The average value from 3 cardiac cycles for each echocardiographic view was used for the statistical analysis. The intra-observer and inter-observer correlation coefficient was 0.98 and 0.94, indicating good reproducibility and reliability.
Statistical Analysis
Statistical analysis was done using SPSS 11.0 for Windows. All data were expressed as mean ± standard deviation. Patients' characteristics according to epicardial fat thickness were compared using an independent t-test and chi-square test. The epicardial fat thickness was also compared with other risk factors and coronary atherosclerosis using one-way ANOVA test. Multivariate analysis was performed to determine the factors related to significant coronary artery stenosis. Statistical significance was set at p<0.05.
Results
In the present series, the patients' mean age was 63.1± 10.4 years and there were 108 male patients (53.2%). The mean value of the epicardial fat thickness was 6.38 mm (range 1.10 to 16.55 mm). There was no difference in epi- cardial fat thickness according to the patient's clinical diagnosis. According to the fourth quartile of epicardial fat thickness, we divided the patients into 2 groups (Group I, fat thickness <7.6 mm; Group II, fat thickness ≥7.6 mm). There were no significant differences in the baseline characteristics, except for waist circumference (p=0.023) ( Table 1) . The incidence of significant coronary artery stenosis increased in proportion to the epicardial fat thickness. The incidence of the significant coronary stenosis was revealed in 33 out of 50 (66.0%) patients within the first quartile (1.10-4.48 mm), 37 out of 51 (72.5%) patients within the second quartile (4.49-6.23 mm), 44 out of 52 (84.6%) patients within the third quartile (6.24-7.59 mm), and 47 out of 50 (94.0%) patients within the fourth quartile of epicardial fat thickness (7.60-16.55 mm) (Fig 2) . An increasing trend in Gensini's score was observed according to the severity of epicardial fat thickness. An ANOVA test showed the significant difference of Gensini's score between the groups according to the quartile of epicardial fat thickness (p=0.014). A post hoc test using Duncan test revealed a significant difference between first quartile patients and other groups of patients (Fig 3) .
A significant correlation was revealed between epicardial fat thickness and age (r=0.332, p<0.001), C-reactive protein (r=0.182, p=0.009), body mass index (r=0.142, p=0.044) and waist circumference (r=0.229, p=0.001) was found ( Table 2) .
Multivariate analysis showed that age (odds ratio (OR) 5.29, p=0.003), epicardial fat thickness (OR 10.53, p= 0.004), diabetes (OR 8.06, p=0.006) and smoking (OR 14.65, p=0.015) were independent factors affecting significant coronary artery stenosis (Table 3) .
Discussion
The present study is the first clinical study indicating that echocardiographic epicardial fat thickness is associated with the severity of coronary artery stenosis in patients with known coronary artery disease.
Obesity is an important risk factor for atherosclerotic cardiovascular disease. Regional body adipose tissue distribution, rather than total body adiposity, has increasingly gained attention as a marker for cardiovascular disease. Hence, the detection of visceral adipose tissue, the fat deposited around the internal organs, might be important for the risk stratification of cardiovascular disease and metabolic syndrome. 1, 6, 17 Epicardial adipose tissue is a true visceral fat tissue, deposited around the heart on the free wall of the right ventricle, left ventricular apex and atrium. Previous reports indi- cated that epicardial adipose tissue is strongly correlated with abdominal fat deposits. 16 This finding was explained through the common embryogenesis pathway; that is, epicardial fat and intra-abdominal fat seem to be originally brown adipose tissue in infancy. The biochemical properties of epicardial fat tissue suggest its possible role as a cardiovascular risk factor. Studies using epicardial fat obtained during coronary artery bypass surgery revealed that a significantly higher expression of interleukin-1, interleukin-6, tumor necrosis factor-and mRNA was shown in epicardial fat than those in leg subcutaneous adipose tissue. 11, 12 Other studies revealed epicardial and omental fat exhibit a comparable pathogenic inflammatory mRNA profile. 13 Therefore, epicardial fat plays a role as a local inflammatory burden and store in patients with coronary artery disease. Until now, magnetic resonance imaging (MRI) has been accepted as a gold standard for measuring epicardial fat thickness. In 2003, Iacobellis et al first reported the development of the echocardiographic measurement of epicardial fat. 14, 16 They showed that echocardiographic epicardial fat thickness has good correlation with MRI abdominal fat and epicardial fat measurements, and anthropometric and metabolic parameters. However, there have been no reports of the correlation between epicardial adipose tissue and the presence and severity of coronary artery disease in a clinical setting. Chaowalit et al performed the first clinical study to confirm this association in 139 patients; however, they failed to demonstrate the association with the severity of coronary artery disease. 18 Our results first established that epicardial fat thickness has a good association with the severity of coronary artery stenosis.
Our analysis was limited by the studied population because it included only those patients pre-selected to undergo coronary angiography. As non-invasive tools for the diagnosis of coronary artery disease have been developed, a population-based prospective study with a large number of patients can be performed. Therefore, an epidemiologic study is required to confirm these results. We could not confirm epicardial fat using the standard MRI methods. Echocardiography was a relatively simple and inexpensive method, but the accuracy and reproducibility should be further tested. In addition, as epicardial adipose tissue has a 3-dimensional distribution, 2-dimensional echocardiography may not completely assess the total amount of epicardial adiposity. Further study will be necessary.
In conclusion, epicardial fat thickness measured using transthoracic echocardiography significantly correlated with the severity of coronary artery stenosis in patients with known coronary artery disease. These findings may enhance the utility of echocardiography as an assessment tool for patients' adiposity and, if confirmed, can assist in the risk stratification of patients with coronary artery disease.
